CADM1 and SPC25 Gene Mutations in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis
Introduction: To investigate the genomic profiles of patients with lung cancer with idiopathic pulmonary fibrosis (IPF-LC), mechanism of carcinogenesis, and potential therapeutic targets. Methods: We analyzed 29 matched, surgically resected, cancerous and noncancerous lung tissues (19 IPF-LC and 10...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/790906db2fa7483283e2b97f1365bd03 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:790906db2fa7483283e2b97f1365bd03 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:790906db2fa7483283e2b97f1365bd032021-12-02T05:03:45ZCADM1 and SPC25 Gene Mutations in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis2666-364310.1016/j.jtocrr.2021.100232https://doaj.org/article/790906db2fa7483283e2b97f1365bd032021-11-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2666364321000916https://doaj.org/toc/2666-3643Introduction: To investigate the genomic profiles of patients with lung cancer with idiopathic pulmonary fibrosis (IPF-LC), mechanism of carcinogenesis, and potential therapeutic targets. Methods: We analyzed 29 matched, surgically resected, cancerous and noncancerous lung tissues (19 IPF-LC and 10 non–IPF-LC) by whole-exome sequencing and bioinformatics analysis and established a medical-engineering collaboration with the Department of Engineering of the Tokyo University of Science. Results: In IPF-LC, CADM1 and SPC25 were mutated at a frequency of 47% (9 of 19) and 53% (10 of 19), respectively. Approximately one-third of the IPF-LC cases (7 of 19; 36%) had both mutations. Pathway analysis revealed that these two genes are involved in transforming growth factor-β1 signaling. CADM1 and SPC25 gene mutations decreased the expression of CADM1 and increased that of SPC25 revealing transforming growth factor-β1–induced epithelial-to-mesenchymal transition and cell proliferation in lung cancer cells. Furthermore, treatment with paclitaxel and DNMT1 inhibitor suppressed SPC25 expression. Conclusions: CADM1 and SPC25 gene mutations may be novel diagnostic markers and therapeutic targets for IPF-LC.Aya Fukuizumi, MDRintaro Noro, MD, PhDMasahiro Seike, MD, PhDAkihiko Miyanaga, MD, PhDYuji Minegishi, MD, PhDMiwako Omori, MDMamiko HiraoKuniko MatsudaShinobu Kunugi, MD, PhDKazutaka NishiwakiMasahiro MorimotoHaruka MotohashiHayato Ohwada, PhDJitsuo Usuda, MD, PhDAkihiko Gemma, MD, PhDElsevierarticleCADM1SPC25Whole-exome sequencingLung cancerIdiopathic pulmonary fibrosisNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENJTO Clinical and Research Reports, Vol 2, Iss 11, Pp 100232- (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
CADM1 SPC25 Whole-exome sequencing Lung cancer Idiopathic pulmonary fibrosis Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
spellingShingle |
CADM1 SPC25 Whole-exome sequencing Lung cancer Idiopathic pulmonary fibrosis Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Aya Fukuizumi, MD Rintaro Noro, MD, PhD Masahiro Seike, MD, PhD Akihiko Miyanaga, MD, PhD Yuji Minegishi, MD, PhD Miwako Omori, MD Mamiko Hirao Kuniko Matsuda Shinobu Kunugi, MD, PhD Kazutaka Nishiwaki Masahiro Morimoto Haruka Motohashi Hayato Ohwada, PhD Jitsuo Usuda, MD, PhD Akihiko Gemma, MD, PhD CADM1 and SPC25 Gene Mutations in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis |
description |
Introduction: To investigate the genomic profiles of patients with lung cancer with idiopathic pulmonary fibrosis (IPF-LC), mechanism of carcinogenesis, and potential therapeutic targets. Methods: We analyzed 29 matched, surgically resected, cancerous and noncancerous lung tissues (19 IPF-LC and 10 non–IPF-LC) by whole-exome sequencing and bioinformatics analysis and established a medical-engineering collaboration with the Department of Engineering of the Tokyo University of Science. Results: In IPF-LC, CADM1 and SPC25 were mutated at a frequency of 47% (9 of 19) and 53% (10 of 19), respectively. Approximately one-third of the IPF-LC cases (7 of 19; 36%) had both mutations. Pathway analysis revealed that these two genes are involved in transforming growth factor-β1 signaling. CADM1 and SPC25 gene mutations decreased the expression of CADM1 and increased that of SPC25 revealing transforming growth factor-β1–induced epithelial-to-mesenchymal transition and cell proliferation in lung cancer cells. Furthermore, treatment with paclitaxel and DNMT1 inhibitor suppressed SPC25 expression. Conclusions: CADM1 and SPC25 gene mutations may be novel diagnostic markers and therapeutic targets for IPF-LC. |
format |
article |
author |
Aya Fukuizumi, MD Rintaro Noro, MD, PhD Masahiro Seike, MD, PhD Akihiko Miyanaga, MD, PhD Yuji Minegishi, MD, PhD Miwako Omori, MD Mamiko Hirao Kuniko Matsuda Shinobu Kunugi, MD, PhD Kazutaka Nishiwaki Masahiro Morimoto Haruka Motohashi Hayato Ohwada, PhD Jitsuo Usuda, MD, PhD Akihiko Gemma, MD, PhD |
author_facet |
Aya Fukuizumi, MD Rintaro Noro, MD, PhD Masahiro Seike, MD, PhD Akihiko Miyanaga, MD, PhD Yuji Minegishi, MD, PhD Miwako Omori, MD Mamiko Hirao Kuniko Matsuda Shinobu Kunugi, MD, PhD Kazutaka Nishiwaki Masahiro Morimoto Haruka Motohashi Hayato Ohwada, PhD Jitsuo Usuda, MD, PhD Akihiko Gemma, MD, PhD |
author_sort |
Aya Fukuizumi, MD |
title |
CADM1 and SPC25 Gene Mutations in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis |
title_short |
CADM1 and SPC25 Gene Mutations in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis |
title_full |
CADM1 and SPC25 Gene Mutations in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis |
title_fullStr |
CADM1 and SPC25 Gene Mutations in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis |
title_full_unstemmed |
CADM1 and SPC25 Gene Mutations in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis |
title_sort |
cadm1 and spc25 gene mutations in lung cancer patients with idiopathic pulmonary fibrosis |
publisher |
Elsevier |
publishDate |
2021 |
url |
https://doaj.org/article/790906db2fa7483283e2b97f1365bd03 |
work_keys_str_mv |
AT ayafukuizumimd cadm1andspc25genemutationsinlungcancerpatientswithidiopathicpulmonaryfibrosis AT rintaronoromdphd cadm1andspc25genemutationsinlungcancerpatientswithidiopathicpulmonaryfibrosis AT masahiroseikemdphd cadm1andspc25genemutationsinlungcancerpatientswithidiopathicpulmonaryfibrosis AT akihikomiyanagamdphd cadm1andspc25genemutationsinlungcancerpatientswithidiopathicpulmonaryfibrosis AT yujiminegishimdphd cadm1andspc25genemutationsinlungcancerpatientswithidiopathicpulmonaryfibrosis AT miwakoomorimd cadm1andspc25genemutationsinlungcancerpatientswithidiopathicpulmonaryfibrosis AT mamikohirao cadm1andspc25genemutationsinlungcancerpatientswithidiopathicpulmonaryfibrosis AT kunikomatsuda cadm1andspc25genemutationsinlungcancerpatientswithidiopathicpulmonaryfibrosis AT shinobukunugimdphd cadm1andspc25genemutationsinlungcancerpatientswithidiopathicpulmonaryfibrosis AT kazutakanishiwaki cadm1andspc25genemutationsinlungcancerpatientswithidiopathicpulmonaryfibrosis AT masahiromorimoto cadm1andspc25genemutationsinlungcancerpatientswithidiopathicpulmonaryfibrosis AT harukamotohashi cadm1andspc25genemutationsinlungcancerpatientswithidiopathicpulmonaryfibrosis AT hayatoohwadaphd cadm1andspc25genemutationsinlungcancerpatientswithidiopathicpulmonaryfibrosis AT jitsuousudamdphd cadm1andspc25genemutationsinlungcancerpatientswithidiopathicpulmonaryfibrosis AT akihikogemmamdphd cadm1andspc25genemutationsinlungcancerpatientswithidiopathicpulmonaryfibrosis |
_version_ |
1718400658937217024 |